Soleno Therapeutics, Inc. · NASDAQ:SLNO

Wellington Management Group LLP reported a 6.20% stake in Soleno Therapeutics, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 10, 2026

Wellington Management Group LLP reported a 6.20% stake in Soleno Therapeutics, Inc., 3,322,799 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G).

Stake
6.20%
Shares
3,322,799
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Wellington Management Group LLP6.20%3,322,799
Wellington Group Holdings LLP6.20%3,322,799
Wellington Investment Advisors Holdings LLP6.20%3,322,799
Wellington Management Company LLP6.00%3,322,799

Source

View original at SEC

Related